gvtcx

NHS England - Market Engagement - Pre Exposure Prophylaxis (PrEP) for prevention of HIV - The PrEP Impact Clinical Trial

key details

Statuscancelled
Category (CPV) 33651400
OCIDocds-b5fd17-60d28e2c-9fb0-43f1-a6c6-8e1edb52c1a7

description

Arden & GEM CSU on behalf of the NHS England - Specialised Commissioning would like to notify all potential bidders about a 'Market Engagement Event' which has been planned to take place on Monday 24th April 2017.

This event has been arranged to provide information and seek feedback about the upcoming procurement of licensed tenofovir disoproxil/emtricitabine combined tablet formulations to meet the aims and objectives of the PrEP Impact Clinical trial.

To attend this event please email your organisation's and attendees' details to mark.perkins@nhs.net

Once you have confirmed your intention to attend, a briefing document will be provided including further details of the event, together with a short questionnaire to be completed and returned on or before the 19th April 2017.

The event will include a briefing for all potential suppliers as well as the opportunity for suppliers to meet individually with members of the NHS England and PHE PrEP Impact Trial team.

The event will be held in central London on Monday 24th April 2017.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
8 Jan 2018 Planning (planning) · d1f2afc4-c358-455e-9da0-e0bc66aaf4b2-190118

more from NHS ARDEN AND GREATER EAST MIDLANDS COMMISSIONING SUPPORT UNIT

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.